| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 | Sep, 2024 |
| Sales | 20 | 10 | 0 | 0 | 0 |
| Sales Growth | +100.00% | unch | unch | unch | unch |
| Net Income | -1,470 | -14,350 | -1,270 | -27,100 | 4,250 |
| Net Income Growth | +89.76% | -1,029.92% | +95.31% | -737.65% | +577.53% |
Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Impact BioMedical Inc. discovers, confirms and patents unique science and technologies resulting in new offerings in human healthcare and wellness. Impact BioMedical Inc. is based in NEW YORK.
Fiscal Year End Date: 12/31